Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.

Purpose: Chemotherapy-induced nausea and vomiting (CINV) is common among cancer patients. Early identification of patients at risk for CINV may help to personalize anti-emetic therapies. To date, few studies have examined the combined contributions of patient-reported and genetic risk factors to CINV.